 |
 |
 Uptake Medical™ "When you can't breathe, nothing else matters" quotes the American Lung Association. Drugs have historically been the first line treatment for chronic obstructive pulmonary disease (COPD). COPD is the 4th leading cause of death in the US claiming nearly 120,000 lives each year. There are over 3 million Americans living with emphysema on a daily basis. Notably, it is the only leading cause of death that is actually increasing in prevalence. Uptake Medical is developing a novel therapy for the treatment of emphysema. Uptake Medical's Bronchoscopic Thermal Vapor Ablation (BTVA) is ideally suited and designed for treating this disease in a safe and effective manner. This proprietary vapor technology allows for a less invasive, interventional approach to lung volume reduction. Leadership Team Board Members |
|
| The Bronchoscopic Thermal Vapor Ablation System (BTVA) is investigational and not approved for use in the United States or abroad. |
|
||
| ©2009 Uptake Medical™ |